| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.4 |